Overview

Evaluation of Liquid vs. Tablet Buprenorphine - 6

Status:
Completed

Trial end date:
2000-08-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the steady-state pharmacokinetics and bioavailability of buprenorphine sublingual tablets vs. sublingual solution.

Phase:

Phase 2

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Treatments:

Buprenorphine